CANTISANI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 594
EU - Europa 281
AS - Asia 112
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 10
SA - Sud America 2
Totale 1.023
Nazione #
US - Stati Uniti d'America 565
CN - Cina 102
IT - Italia 65
NL - Olanda 56
IE - Irlanda 55
FI - Finlandia 39
CI - Costa d'Avorio 24
CA - Canada 20
SE - Svezia 18
UA - Ucraina 13
DE - Germania 12
A1 - Anonimo 10
MX - Messico 9
GB - Regno Unito 8
FR - Francia 5
RU - Federazione Russa 4
KR - Corea 3
CH - Svizzera 2
CL - Cile 2
ID - Indonesia 2
IN - India 2
NO - Norvegia 2
PK - Pakistan 1
PL - Polonia 1
PT - Portogallo 1
SG - Singapore 1
TR - Turchia 1
Totale 1.023
Città #
Chandler 133
Amsterdam 56
Millbury 51
Princeton 39
Ashburn 35
Beijing 31
Nanjing 31
Jacksonville 23
Ottawa 20
Wilmington 14
Naples 12
Boston 10
Des Moines 10
Napoli 10
Kronberg 7
Shenyang 7
Jiaxing 6
San Martín 6
Nanchang 5
Paris 5
Redwood City 5
Tianjin 5
Vertova 5
Falls Church 4
Hangzhou 4
Hebei 4
Hefei 4
Indiana 3
Norwalk 3
Boardman 2
Changsha 2
Cheongju-si 2
Houston 2
Jakarta 2
Kunming 2
Los Angeles 2
Manchester 2
New York 2
Orange 2
Oslo 2
Pozzuoli 2
Pune 2
Santiago 2
Trecase 2
Washington 2
Caserta 1
Dublin 1
Gdansk 1
Giugliano In Campania 1
Islamabad 1
La Paz 1
Leawood 1
Longmeadow 1
Milan 1
Nocera Superiore 1
Rome 1
Sorrento 1
Torino 1
Yellow Springs 1
Totale 594
Nome #
Pathophysiological changes of gram-negative bacterial infection can be reproduced by a synthetic peptide mimicking loop L7 sequence of Haemophilus influenzae porin 45
Biocompatible nanoparticles sensing the matrix metallo-proteinase 2 for the on-demand release of anticancer drugs in 3D tumor spheroids 45
Defensins as a therapeutic target for infectious diseases. 41
Membrane Fusion and Fission: enveloped viruses 40
Peptides containing membrane-interacting motifs inhibit herpes simplex virus type 1 infectivity 38
The intersubunit region of influenza virus haemoagglutinin as a peptide vaccine candidate 37
Biophysical characterization and membrane interaction of the two fusion loops of glycoprotein B from herpes simplex type I virus. 36
Microbe-host interactions: structure and role of Gram-negative bacterial porins. 36
Silver Nanoparticles as Novel Antibacterial and Antiviral Agents 34
Design and activity of a cyclic mini-β-defensin analog: a novel antimicrobial tool 34
Novel synthetic, salt-resistant analogs of human beta-defensins 1 and 3 endowed with enhanced antimicrobial activity 32
beta-barrel membrane bacterial proteins: structure, function, assembly and interaction with lipids 32
Peptide inhibitors against herpes simplex virus infections. 31
Viral Peptide Targeted Delivery of Nano-Therapeutics 31
Tumor-activated prodrug (TAP) - conjugated nanoparticles with cleavable domains for safe doxorubicin delivery 31
Biophysical characterization and membrane interaction of the two fusion loops of glycoprotein B from herpes simplex virus type I 31
A peptide derived from Herpes Simplex Virus type 1 glycoprotein H: membrane translocation and applications to the delivery of quantum dots 30
Metal nanoparticles as antiviral agents 28
A viral peptide for intracellular delivery 28
Viral Peptide Targeted Delivery of Nano-Therapeutics 28
The identification and characterization of fusogenic domains in herpes virus glycoprotein B molecules 27
Review of a viral peptide nanosystem for intracellular delivery 26
Proteomic analysis of human U937 cell line activation mediated by Haemophilus influenzae type b P2 porin and its surface-exposed loop 7. 25
P2 porin and loop 7 from Haemophilus influenzae modulate expression of IL-6 and adhesion molecules in astrocytes 25
Conformational modifications of gB from Herpes simplex virus type 1 analyzed by synthetic peptides 25
Mapping key interactions in the dimerization process of HBHA from Mycobacterium tuberculosis, insights into bacterial agglutination. 23
Peptides complementary to the active loop of porin P2 from Haemophilus influenzae modulate its activity. 23
Conformational modifications of gB from Herpes simplex virus type 1 analyzed by synthetic peptides 23
Intracellular delivery: exploiting viral membranotropic peptides. 22
Structural Requirements for Proinflammatory Activity of Porin P2 Loop 7 from Haemophilus influenzae. 21
Septic shock by gram-negative infections: role of outer membrane proteins 19
Peptides complementary to the active loop of porin P2 from Haemophilus influenzae modulate its acti 19
Structure activity relations of Myxinidin, an antibacterial peptide derived from Epidermal Mucus of Hagfish. 18
Structural determinats of M. tuberculosis agglutination guided by Heparin Binding Hemagglutinin A 17
Structural Insights into and Activity Analysis of the Antimicrobial Peptide Myxinidin 17
Structure and orientation of the gH625-644 membrane interacting region of herpes simplex virus type 1 in a membrane mimetic system. 16
Peptide-lipid interactions: experiments and applications. 16
Viral Fusion Peptides Induce Several Signal Transduction Pathways Activation That Are Essential For Il-10 and -Interferon Production. 15
Novel analogs of human beta defensins 1 and 3 showed enhanced antimicrobial activity 13
Totale 1.078
Categoria #
all - tutte 4.389
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.389


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 0 4 0 0
2019/2020147 61 0 5 1 20 1 0 0 2 15 28 14
2020/202162 1 4 8 3 4 25 7 0 4 2 4 0
2021/2022237 7 2 1 2 0 6 0 9 60 22 43 85
2022/2023334 39 14 23 17 39 37 1 31 56 59 13 5
2023/2024152 6 34 22 13 14 28 2 31 0 2 0 0
Totale 1.078